Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,494 | 132,180 | 29,698 | 22,928 | 43,368 |
| Marketable Securities | 333,477 | 337,584 | 264,109 | 406,090 | 464,535 |
| Receivables | 1,423 | 2,143 | 5,228 | 8,485 | 54,038 |
| Other current assets | 0 | 2,264 | 604 | 0 | 0 |
| TOTAL | $353,976 | $481,313 | $310,927 | $458,771 | $591,221 |
| Non-Current Assets | |||||
| PPE Net | 7,667 | 9,959 | 27,193 | 31,787 | 47,927 |
| Investments And Advances | 1,312 | 11,427 | 16,196 | 35,515 | 45,272 |
| Intangibles | 11,153 | 14,220 | 23,109 | 26,066 | 21,139 |
| Other Non-Current Assets | 0 | 0 | 2,120 | 0 | 0 |
| TOTAL | $20,132 | $35,606 | $68,618 | $93,368 | $114,338 |
| Total Assets | $374,108 | $516,919 | $379,545 | $552,139 | $705,559 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,955 | 8,538 | 10,266 | 12,976 | 11,407 |
| Accrued Expenses | 18,298 | 18,587 | 25,323 | 52,129 | 45,655 |
| Other current liabilities | N/A | N/A | N/A | 926 | 5,001 |
| TOTAL | $27,857 | $31,481 | $41,990 | $77,693 | $86,108 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 604 | 1,807 | 4,534 | 11,662 | 24,045 |
| Other Non-Current Liabilities | 365,648 | 406,921 | 183,222 | 172,036 | 179,248 |
| TOTAL | $365,648 | $406,921 | $183,222 | $172,036 | $179,248 |
| Total Liabilities | $393,505 | $438,402 | $225,212 | $249,729 | $265,356 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,644 | 83,029 | 72,674 | 70,796 | 66,898 |
| Common Shares | 84 | 83 | 73 | 67 | 67 |
| Retained earnings | -839,347 | -736,304 | -571,487 | -405,024 | -268,139 |
| Other shareholders' equity | 1,228 | -2,412 | -1,215 | -796 | 863 |
| TOTAL | $-19,397 | $78,517 | $154,333 | $302,410 | $440,203 |
| Total Liabilities And Equity | $374,108 | $516,919 | $379,545 | $552,139 | $705,559 |